CIDRAP | The updated National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025 is a roadmap to guide the nation’s response to the rise and spread of drug-resistant bacteria. The five goals of the plan remain the same as those in the first plan, which came out in March 2015. But the objectives for meeting those goals have been updated. Among the new objectives are a 20% reduction in the number of healthcare-associated antibiotic-resistant infections and 10% reduction in community-acquired antibiotic-resistant infections by 2025, support for 10 new resistance-related diagnostics projects by 2021, and support for the clinical development of 10 novel therapeutics for bacterial infections by 2022.